Page 7 - Daniel Altmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A new report suggests that the Pfizer-BioNTech vaccine is effective against the new, more contagious strains of COVID from the U.K. and South Africa.

| UPDATED: 17:30, Fri, Jan 8, 2021 Link copied Sign up for FREE health tips to live a long and happy life SUBSCRIBE Invalid email When you subscribe we will use the information you provide to send you these newsletters. Sometimes they'll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time. The UK and South African COVID-19 variants have been found to share a common mutation which makes them more infectious. As such, Pfizer teamed up with researchers from th...

Having one of the new coronavirus vaccines does not mean Britons, including pensioners, can act with 'wild abandon and go off to the bingo halls', the Deputy chief medical officer has said.    Professor Jonathan Van-Tam was asked at Wednesday's Downing Street press conference whether people who have had two doses of a vaccine would still have to follow strict rules such as not seeing their families. The scientist defined the question as whether 'it's OK to behave with wild abandon and go off to the bingo halls and so forth'. He said a lot was still unknown about whether jabs stopped people...

The approval of the Oxford-AstraZeneca vaccine has been hailed as a “game-changer” and a “triumphant moment” in the battle against coronavirus. One of the key people behind the new jab said it will provide some respite in the “blizzard” of the pandemic, and hope for the future. Professor Andrew Pollard, director of the Oxford Vaccine Group and chief investigator of the Oxford Vaccine Trial, said the development and approval of the vaccine is “an absolute triumph of academic collaboration”. He told BBC’s Radio Radio 4 Today programme: “This really is a great moment in what�...

The approval of the Oxford-AstraZeneca vaccine has been hailed as a “game-changer” and a “triumphant moment” in the battle against coronavirus. One of the key people behind the new jab said it will provide some respite in the “blizzard” of the pandemic, and hope for the future. Professor Andrew Pollard, director of the Oxford Vaccine Group and chief investigator of the Oxford Vaccine Trial, said the development and approval of the vaccine is “an absolute triumph of academic collaboration”. He told BBC’s Radio Radio 4 Today programme: “This really is a great moment in what�...